Balyasny Asset Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Balyasny Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $2.33 Million - $2.91 Million	-54,190 Reduced 65.34%	28,743 $1.34 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $2.63 Million - $4.08 Million	82,933 New	82,933 $3.97 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $41,104 - $56,476	1,219 New	1,219 $56,000
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $261,891 - $312,166	-3,553 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $276,849 - $363,827	3,553 New	3,553 $320,000
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $425,180 - $533,654	-4,612 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $496,657 - $779,273	-4,646 Reduced 50.18%	4,612 $525,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $781,375 - $1.64 Million	9,258 New	9,258 $1.28 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $282,253 - $358,528	-7,823 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $332,477 - $493,709	7,823 New	7,823 $335,000
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $661,027 - $894,848	-12,034 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$39.87 - $69.36 $104,220 - $181,307	-2,614 Reduced 17.85%	12,034 $835,000
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $569,660 - $1.13 Million	14,648 New	14,648 $637,000
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $416,702 - $550,088	-9,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $409,276 - $538,808	9,400	9,400 $436,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.8B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.